catheter-related infections
Conditions
Interventions
experimental group:subcutaneous tunneled subclavian venous catheterization
control group:subclavian venous catheterization
Sponsors
Department of Neurosurgery, Nanfang Hospital, Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-65 years, male or female; 2. The subclavian central vein is placed for the first time; 3. Catheter was inserted into the subclavian vein; 4. The time of keeping central venous catheter is >=3 days 5. The patient/family is informed and voluntarily signs the informed consent.
Exclusion criteria
Exclusion criteria: 1. The skin at the puncture site is injured before puncture; 2. Known allergy to any drug before the trial; 3. Participate in another clinical trial; 4. Emergency catheter insertion; 5. Obvious thrombus/stenosis of the central vein; 6. Platelet count 1.6 times of the normal range, and partial thrombin activity time >2 times of the normal range, or have therapeutic anticoagulation; 7. Severe hypoxemia (oxygenation index 35 kg/m2 for male and > 30 kg/m2 for female; 9. Positive pregnancy test for women or lactating women; 10. Patients considered inappropriate by the investigator to participate in clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catheter related infection; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of catheter-related thrombus;mechanical complications: arterial puncture, pneumothorax, hemothorax, mediastinal hematoma, wrong location of tip of catheter , local hematoma or hemorrhage, air embolism.;operational time to establish the central venous catheter.;accuracy of measurement of central venous pressure; | — |
Countries
China
Contacts
Public ContactYun Bao
Department of Neurosurgery, Nanfang Hospital, Southern Medical University
Outcome results
None listed